brain metastases

Showing 1 - 25 of 269

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Renal Cell Carcinoma, Brain Metastases Trial in United States (drug, device, radiation)

Recruiting
  • Metastatic Renal Cell Carcinoma
  • Brain Metastases
  • Basking Ridge, New Jersey
  • +6 more
Nov 10, 2023

Brain Tumor, Brain Necrosis, Brain Metastases Trial in Cleveland (MRF in conjunction with IVIM MRI without contrast)

Not yet recruiting
  • Brain Tumor
  • +2 more
  • MRF in conjunction with IVIM MRI without contrast
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Center
Oct 20, 2023

Breast Cancer, Brain Metastases, Radiotherapy Trial in Shanghai (Combination use of SRT with T-DXd)

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Combination use of SRT with T-DXd
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Oct 14, 2023

Breast Cancer, Brain Metastases Trial in New York (Brain Imaging with 18F-FES)

Not yet recruiting
  • Breast Cancer
  • Brain Metastases
  • Brain Imaging with 18F-FES
  • New York, New York
    New York-Presbyterian/Weill Cornell Medical Center
Oct 2, 2023

Brain Metastases Trial in Tucson (18F-Fluciclovine PET/CT)

Not yet recruiting
  • Brain Metastases
  • 18F-Fluciclovine PET/CT
  • Tucson, Arizona
    Arizona Cancer Center at UMC North/University Medical Center
Sep 20, 2023

Preclinical Brain Tumor Models

Recruiting
  • Brain Metastases
  • Diffuse Gliomas
  • Fresh tumor sampling
  • Marseille, France
    Assistance publique hopitaux de marseille
Sep 13, 2023

Brain Metastases, Brain Metastases, Adult, Brain Cancer Trial in Miami (18F fluciclovine)

Not yet recruiting
  • Brain Metastases
  • +2 more
  • 18F fluciclovine
  • Miami, Florida
    Miami Cancer Institute
Sep 15, 2023

Brain Metastases, NSCLC Trial in Shanghai (EGFR-TK Inhibitor, Stereotactic radiotherapy)

Recruiting
  • Brain Metastases
  • Non-small Cell Lung Cancer
  • EGFR-TK Inhibitor
  • Stereotactic radiotherapy
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 27, 2023

Brain Metastases Trial in Houston (18F-Fluciclovine (Axumin), Pet Scan)

Not yet recruiting
  • Brain Metastases
  • 18F-Fluciclovine (Axumin)
  • Pet Scan
  • Houston, Texas
    M D Anderson Cancer Center
Aug 23, 2023

Head and Neck Squamous Cell Carcinoma, Brain Metastases Trial in Nashville (Magnetic Resonance Imaging (MRI), Positron Emission

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Brain Metastases
  • Magnetic Resonance Imaging (MRI)
  • +2 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Aug 10, 2023

Lung Cancer, NSCLC, Brain Metastases Trial (Alectinib, Stereotactic Radiosurgery)

Not yet recruiting
  • Lung Cancer
  • +2 more
  • (no location specified)
Aug 4, 2023

Brain Metastases, Radionecrosis, Pulmonary Cancer Trial in Paris (MRI with CEST sequence, IVIM and ASL sequence)

Not yet recruiting
  • Brain Metastases
  • +2 more
  • MRI with CEST sequence, IVIM and ASL sequence
  • Paris, France
    Hôpital Bichat-Claude Bernard
Aug 3, 2023

NSCLC, EGFR Activating Mutation, Brain Metastases Trial in Beijing (TY-9591, Osimertinib)

Not yet recruiting
  • NSCLC
  • +2 more
  • Beijing, Beijing, China
    National Cancer Center/Cancer Hospitial,Chinese Academy of Medic
Jul 9, 2023

Brain Metastases Trial (Gamma Tile-Surgically Targeted Radiation Therapy (STaRT), Stereotactic Radiation Therapy)

Not yet recruiting
  • Brain Metastases
  • Gamma Tile-Surgically Targeted Radiation Therapy (STaRT)
  • Stereotactic Radiation Therapy
  • (no location specified)
Jun 2, 2023

Brain Metastases, Radiotherapy Trial in Heidelberg (Preoperative Radiotherapy, Intraoperative Radiation, Postoperative

Not yet recruiting
  • Brain Metastases
  • Radiotherapy
  • Preoperative Radiotherapy
  • +2 more
  • Heidelberg, Germany
    Department of Radiotherapy, University of Heidelberg
May 12, 2023

Brain Metastases, Radiosurgery Trial in Seoul (Magnetic resonance imaging (MRI), Diffusion-weighted MRI, Arterial spin labeling

Not yet recruiting
  • Brain Metastases
  • Radiosurgery
  • Magnetic resonance imaging (MRI)
  • +3 more
  • Seoul, Korea, Republic of
    Asan Medical Center
May 11, 2023

Brain Metastases Trial (biological samples (blood test and lumbar puncture))

Not yet recruiting
  • Brain Metastases
  • biological samples (blood test and lumbar puncture)
  • (no location specified)
May 4, 2023

Non Small Cell Lung Cancer, Brain Metastases Trial (Cadonilimab)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Brain Metastases
  • (no location specified)
Apr 2, 2023

NSCLC Stage II, Bevacizumab, Immunotherapy Trial in Guangzhou (Serplulimab combined with bevacizumab and first-line chemo)

Not yet recruiting
  • Non-small Cell Lung Cancer Stage II
  • +3 more
  • Serplulimab combined with bevacizumab and first-line chemotherapy
  • Guangzhou, Guangdong, China
    Likun Chen
Apr 10, 2023

NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +32 more
  • (no location specified)
Mar 30, 2023

Cancer, Metastasis, Metastatic Cancer Trial in Miami (Azeliragon, Stereotactic radiosurgery, Corticosteroid)

Not yet recruiting
  • Cancer
  • +4 more
  • Miami, Florida
    Miami Cancer Institute at Baptist Health, Inc.
Mar 16, 2023

Brain Metastases, Radiotherapy, EGFR Activating Mutation Trial in Guangdong (brain radiotherapy, Almonertinib)

Recruiting
  • Brain Metastases
  • +2 more
  • Guangdong, Guangzhou, China
    Sun-Yat-Sen university
Mar 13, 2023

Brain Metastases, Radiation Necrosis Trial in Amiens (early 18F-FDOPA uptake)

Recruiting
  • Brain Metastases
  • Radiation Necrosis
  • early 18F-FDOPA uptake
  • Amiens, Picardie, France
    CHU Amiens
Mar 9, 2023

Circulating Tumor DNA and T Cell Repertoire Predict

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Brain Metastases
  • Whole-brain radiotherapy
  • Wuhan, Hubei, China
    Union hospital
Feb 12, 2023

Brain Metastases Trial in Houston (Niraparib, Dostarlimab)

Not yet recruiting
  • Brain Metastases
  • Houston, Texas
    M D Anderson Cancer Center
Jan 17, 2023